TiD: Standalone software for mining putative drug targets from bacterial proteome

Area of Science:

• Bioinformatics
• Drug Discovery
• Computational Biology

Background:

• Identifying essential and pathogen-specific proteins is crucial for effective drug target selection.
• Existing methods may lack efficiency or comprehensive analysis for identifying viable drug targets.

Purpose of the Study:

• To introduce TiD, a standalone application designed for the identification of essential and non-homologous proteins as putative drug targets.
• To provide a comprehensive analysis pipeline including pathway, interactome, and localization studies for proposed targets.

Main Methods:

• TiD filters bacterial proteomes by removing paralogs and selecting essential proteins.
• It excludes proteins homologous to host organisms, ensuring specificity.
• Targets are further assessed for non-homology with a panel of safe gut microbes and classified as known, novel, or virulent.

Main Results:

• TiD successfully identifies essential and non-homologous proteins, demonstrating non-homology with at least 40 out of 84 safe gut microbes.
• The application classifies targets into known, novel, and virulent categories.
• Drug targets identified for Listeria monocytogenes, Bacillus anthracis, and Pseudomonas aeruginosa show significant overlap with previous findings.
• TiD processes a ~5000 protein bacterial proteome in under 2 hours.

Conclusions:

• TiD is an efficient and valuable tool for rational drug design, accelerating the identification of potential therapeutic targets.
• The application offers integrated analysis features, enhancing the utility of identified targets.
• TiD's speed and comprehensive approach make it a significant contribution to antimicrobial drug discovery efforts.